Found: 42
Select item for more details and to access through your institution.
Development, Characterization, and Radiation Dosimetry Studies of <sup>18</sup>F-BMS-986229, a <sup>18</sup>F-Labeled PD-L1 Macrocyclic Peptide PET Tracer.
- Published in:
- Molecular Imaging & Biology, 2024, v. 26, n. 2, p. 301, doi. 10.1007/s11307-023-01889-4
- By:
- Publication type:
- Article
The discovery and evaluation of [<sup>18</sup>F]BMS-986229, a novel macrocyclic peptide PET radioligand for the measurement of PD-L1 expression and in-vivo PD-L1 target engagement.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 4, p. 978, doi. 10.1007/s00259-023-06527-3
- By:
- Publication type:
- Article
Synthesis of a dual carbon‐14‐labeled calcitonin gene‐related peptide receptor antagonist for use in a human absorption–distribution–metabolism–elimination study.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2022, v. 65, n. 5, p. 126, doi. 10.1002/jlcr.3966
- By:
- Publication type:
- Article
Synthesis of carbon‐14 and stable isotope labeled Censavudine.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2022, v. 65, n. 4, p. 112, doi. 10.1002/jlcr.3964
- By:
- Publication type:
- Article
Synthesis and Preclinical Evaluation of <sup>68</sup>Ga-labeled Adnectin, <sup>68</sup>Ga-BMS-986192 as a PET Agent for Imaging PD-L1 Expression.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.258384
- By:
- Publication type:
- Article
Synthesis and Preclinical Evaluation of <sup>68</sup>Ga-labeled Adnectin, <sup>68</sup>Ga-BMS-986192 as a PET Agent for Imaging PD-L1 Expression.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.258384
- By:
- Publication type:
- Article
Synthesis of tritium labeled 30‐KDa PEG and conjugation to form [<sup>3</sup>H]Pegbelfermin.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2021, v. 64, n. 12, p. 477, doi. 10.1002/jlcr.3940
- By:
- Publication type:
- Article
Synthesis and Preclinical Evaluation of <sup>68</sup>Ga-labeled Adnectin, <sup>68</sup>Ga-BMS-986192 as a PET Agent for Imaging PD-L1 Expression.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.258384
- By:
- Publication type:
- Article
Synthesis and Preclinical Evaluation of <sup>68</sup>Ga-labeled Adnectin, <sup>68</sup>Ga-BMS-986192 as a PET Agent for Imaging PD-L1 Expression.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.258384
- By:
- Publication type:
- Article
Synthesis and Preclinical Evaluation of <sup>68</sup>Ga-labeled Adnectin, <sup>68</sup>Ga-BMS-986192 as a PET Agent for Imaging PD-L1 Expression.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.258384
- By:
- Publication type:
- Article
Synthesis and Preclinical Evaluation of <sup>68</sup>Ga-labeled Adnectin, <sup>68</sup>Ga-BMS-986192 as a PET Agent for Imaging PD-L1 Expression.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 1, doi. 10.2967/jnumed.120.258384
- By:
- Publication type:
- Article
Synthesis and Preclinical Evaluation of <sup>68</sup>Ga-labeled Adnectin, <sup>68</sup>Ga-BMS-986192 as a PET Agent for Imaging PD-L1 Expression.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.258384
- By:
- Publication type:
- Article
Synthesis and Preclinical Evaluation of <sup>68</sup>Ga-labeled Adnectin, <sup>68</sup>Ga-BMS-986192 as a PET Agent for Imaging PD-L1 Expression.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 3, p. 1, doi. 10.2967/jnumed.120.258384
- By:
- Publication type:
- Article
Synthesis of stable‐isotope‐labeled N‐(3‐dimethylaminopropyl)‐N′‐ethylcarbodiimide and N‐(3‐dimethylaminopropyl)‐N′‐ethylurea.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2020, v. 63, n. 13, p. 526, doi. 10.1002/jlcr.3877
- By:
- Publication type:
- Article
Synthesis of unlabelled and stable-isotope-labelled glucuronide metabolites of dapagliflozin and synthesis of stable-isotope-labelled dapagliflozin.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2017, v. 60, n. 3, p. 150, doi. 10.1002/jlcr.3484
- By:
- Publication type:
- Article
The synthesis and analysis of [phenyl-<sup>14</sup>C(U)]BMS-770767 and [<sup>13</sup>C<sub>6</sub>]BMS-770767 for use in discovery biotransformation, human ADME and bioanalytical studies.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2016, v. 59, n. 14, p. 657, doi. 10.1002/jlcr.3428
- By:
- Publication type:
- Article
The syntheses of isotopically labelled CB-1 antagonists for the treatment of obesity.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2016, v. 59, n. 14, p. 665, doi. 10.1002/jlcr.3433
- By:
- Publication type:
- Article
The syntheses of [<sup>14</sup>C]BMS-823778 for use in a human ADME clinical study and of [<sup>13</sup>CD<sub>3</sub><sup>13</sup>CD<sub>2</sub>]BMT-094817, a stable-isotope labeled standard of a newly detected human metabolite.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2016, v. 59, n. 6, p. 255, doi. 10.1002/jlcr.3383
- By:
- Publication type:
- Article
Synthesis of isotopically labeled daclatasvir for use in human clinical studies.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2016, v. 59, n. 4, p. 164, doi. 10.1002/jlcr.3386
- By:
- Publication type:
- Article
Synthesis of stable isotope-labeled epothilone D using a degradation-reconstruction approach.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2015, v. 58, n. 9, p. 361, doi. 10.1002/jlcr.3312
- By:
- Publication type:
- Article
The synthesis of <sup>14</sup>C-labeled N-succinimidyl-3-maleimidopropionate, a linker molecule for PEGylated biologics.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2014, v. 57, n. 12, p. 667, doi. 10.1002/jlcr.3225
- By:
- Publication type:
- Article
Synthesis of carbon-14 and stable isotope labeled Avagacestat: a novel gamma secretase inhibitor for the treatment of Alzheimer's disease.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2014, v. 57, n. 10, p. 600, doi. 10.1002/jlcr.3224
- By:
- Publication type:
- Article
Synthesis of a stable isotopically labeled universal surrogate peptide for use as an internal standard in LC-MS/MS bioanalysis of human IgG and Fc-fusion protein drug candidates.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2014, v. 57, n. 9, p. 579, doi. 10.1002/jlcr.3218
- By:
- Publication type:
- Article
The synthesis of <sup>14</sup>C-labeled, <sup>13</sup>CD<sub>2</sub>-labeled saxagliptin, and its <sup>13</sup>CD<sub>2</sub>-labeled 5-hydroxy metabolite.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2014, v. 57, n. 3, p. 136, doi. 10.1002/jlcr.3179
- By:
- Publication type:
- Article
Synthesis of [3 α-<sup>3</sup>H] 17 α-Hydroxy pregnenolone and [3 α-<sup>3</sup>H] Pregnenolone.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2014, v. 57, n. 1, p. 1, doi. 10.1002/jlcr.3114
- By:
- Publication type:
- Article
An alternative and robust synthesis of [<sup>13</sup>C<sub>4</sub>]Baraclude® (entecavir).
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2013, v. 56, n. 12, p. 632, doi. 10.1002/jlcr.3064
- By:
- Publication type:
- Article
An improved synthesis of [2-<sup>14</sup>C]2, 5-dichloropyrimidine.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2012, v. 55, n. 8, p. 300, doi. 10.1002/jlcr.2937
- By:
- Publication type:
- Article
Synthesis of [D<sub>4</sub>]- and [D<sub>7</sub>]-4 β-hydroxycholesterols for use in a novel drug-drug interaction assay.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2012, v. 55, n. 2, p. 61, doi. 10.1002/jlcr.1952
- By:
- Publication type:
- Article
A novel synthesis of [2-<sup>14</sup>C]2,5-dichloropyrimidine.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2011, v. 54, n. 13, p. 813, doi. 10.1002/jlcr.1940
- By:
- Publication type:
- Article
The syntheses and in vitro biotransformation studies of [<sup>14</sup>C]apixaban, a highly potent, selective, efficacious and orally bioavailable inhibitor of blood coagulation Factor Xa.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2011, v. 54, n. 8, p. 418, doi. 10.1002/jlcr.1890
- By:
- Publication type:
- Article
The.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2011, v. 54, n. 6, p. 324, doi. 10.1002/jlcr.1871
- By:
- Publication type:
- Article
Synthesis and stability of a carbon-14-labeled 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitor.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2011, v. 54, n. 2, p. 72, doi. 10.1002/jlcr.1810
- By:
- Publication type:
- Article
Carbon-14 labeled methyl 2-chloro-2-oxoacetate: a convenient carbon-14 labeled oxalyl chloride equivalent.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2009, v. 52, n. 13, p. 549, doi. 10.1002/jlcr.1673
- By:
- Publication type:
- Article
Distinguishing a phosphate ester prodrug from its isobaric sulfate metabolite by mass spectrometry without the metabolite standard.
- Published in:
- Rapid Communications in Mass Spectrometry: RCM, 2009, v. 23, n. 19, p. 3107, doi. 10.1002/rcm.4228
- By:
- Publication type:
- Article
Synthesis of carbon-14 labelled midazolam.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2009, v. 52, n. 10, p. 419, doi. 10.1002/jlcr.1620
- By:
- Publication type:
- Article
Synthesis of lead LFA-1 antagonist [<sup>14</sup>C]spyrocyclic hydantoin.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2009, v. 52, n. 6, p. 236, doi. 10.1002/jlcr.1596
- By:
- Publication type:
- Article
Synthesis of [1,2-<sup>3</sup>H]ethylamine hydrochloride and [<sup>3</sup>H]-labeled apadenoson for a human ADME study.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2008, v. 51, n. 2, p. 113, doi. 10.1002/jlcr.1495
- By:
- Publication type:
- Article
Synthesis of <sup>14</sup>C-labeled and <sup>13</sup>C-,<sup>15</sup>N-labeled dasatinib and its piperazine N-dealkyl metabolite.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2008, v. 51, n. 1, p. 41, doi. 10.1002/jlcr.1469
- By:
- Publication type:
- Article
Carbon-14 labeling of Saxagliptin (BMS-477118).
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2007, v. 50, n. 13, p. 1224, doi. 10.1002/jlcr.1450
- By:
- Publication type:
- Article
Synthesis of the anxiolytic agent [<sup>14</sup>C] 6-hydroxy-buspirone for use in a human ADME study.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2007, v. 50, n. 2, p. 65, doi. 10.1002/jlcr.1148
- By:
- Publication type:
- Article
Synthesis of multi-labeled [<sup>14</sup>C]Aripiprazole.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2006, v. 49, n. 1, p. 1, doi. 10.1002/jlcr.1017
- By:
- Publication type:
- Article
A facile and efficient synthesis of d<sub>3</sub>-labelled Reyataz™.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2005, v. 48, n. 14, p. 1041, doi. 10.1002/jlcr.1019
- By:
- Publication type:
- Article